Prevalence and correlates of anergy among drug users in Puerto Rico

International Journal of Epidemiology

Volumn 28, Issue 3, 1999, Pages 509-513

  Robles, Rafaela R ^a,b   Reyes, Juan C ^a   Colón, Héctor M ^a,b   Matos, Tomás D ^b   Pérez, Luis Vilá ^c   Marrero, C Amalia ^b  

^a SCHOOL OF MEDICINE   (Puerto Rico)

^b Research Institute   (Puerto Rico)

^c Universidad Central del Caribe School of Medicine   (Puerto Rico)

Author keywords

Anergy; Drug users; HIV AIDS; Mycobacterium tuberculosis infection

Indexed keywords

COCAINE;

DISEASE PREVALENCE; HUMAN IMMUNODEFICIENCY VIRUS; URBAN SOCIETY;

ADULT; ARTICLE; CLONAL ANERGY; DRUG ABUSE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE SYSTEM; IMMUNOPATHOLOGY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PUERTO RICO; TUBERCULOSIS;

ADULT; CLONAL ANERGY; FEMALE; HUMANS; MALE; PREVALENCE; PUERTO RICO; SEROEPIDEMIOLOGIC STUDIES; SOCIOECONOMIC FACTORS; SUBSTANCE ABUSE, INTRAVENOUS;

PUERTO RICO;

EID: 0033063251     PISSN: 03005771     EISSN: None     Source Type: Journal    
DOI: 10.1093/ije/28.3.509     Document Type: Article

References (22)

1. Grandes-Odriozola G, Lopez de Munain J, Martinez-Cruz AS. Prevención, Diagnóstico y Tratamiento de la Tuberculosis en Puerto Rico [Prevention, diagnosis and treatment of tuberculosis in Puerto Rico]. San Juan, PR: PR Department of Health, Central Office for Issues on AIDS and STD, TB Control Program, 1991.
2. Whalen C, Horsburgh CR, Hom D, Lahart C, Simberkoff M, Ellner J. Accelerated course of human immunodeficiency virus infection after tuberculosis. Am J Respir Crit Care Med 1995;151:129-35.
3. Kornbluth RS, McCutchan JA. Skin test responses as predictors of tuberculous infection and of progression in HIV-infected persons (editorial). Ann Intern Med 1993;119:241-42.
4. Moreno S, Baraia-Extaburu J, Bouza E et al. Risk for developing tuberculosis among anergic patients infected with HIV. Ann Intern Med 1993;119:194-98.
5. Selwyn PA, Ackell BM, Alcaber P, Friedland GH, Klein RS, Schoenbaum EE. High risk of active tuberculosis in HIV-infected drug users with cutaneous anergy. JAMA 1992;268:504-09.
6. Reyes JC, Robles RR, Colon HM, Marrero CA, Castillo X, Melendez M. Mycobacterium tuberculosis infection among crack and injection drug users in San Juan, Puerto Rico. PR Health Sci J 1996;15:233-36.
7. Matos TD, Robles RR, Marrero CA, Colón HM. Crack use in Puerto Rico: Evidence of a recent epidemic. PR Health Sci J 1996;15:221-25.
8. Graham NMH, Nelson KE, Solomon L et al. Prevalence of tuberculin positivity and skin test anergy in HIV-1-seropositive and -seronegative intravenous drug users. JAMA 1992;267:369-73.
9. Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report 1997;9:1-39.
10. Robles RR, Colón HM, Sahai H, Matos TD, Marrero CA, Reyes JC. Behavioral risk factors and HIV prevalence among intravenous drug users in Puerto Rico. Am J Epidemiol 1992;135:531-40.
11. Colón HM, Robles RR, Sahai H, Reyes JC, Matos TD. HIV seroprevalence among injection drug users in Puerto Rico: A comparative perspective. In: Brown BS, Beschner GM (eds). Handbook on Risk of AIDS: Injection Drug Users and Sexual Partners. Westport, CT: Greenwood Publishing Group, Inc., 1993, pp.72-87.
12. Weatherby NL, Needle R, Cesari H et al. Validity of self-reported drug use among injection drug users and crack cocaine users recruited through street outreach. J Educ Prog Plan 1994;17:347-55.
13. Stimpson PG, Paty JG, Hudson T, Lieberman P. Delayed hyper-sensitivity skin testing for assessing anergy in the mid-south. South Med J 1975;69:424-26.
14. Sokal JE. Measurement of delayed skin-test responses (Ed.). N Engl J Med 1975;293:501-02.
15. Mientjes GH, Miedema F, van Ameijden EJ et al. Frequent injecting impairs lymphocyte reactivity in HIV-positive and HIV-negative drug users. AIDS 1991;3:35-41.
16. Sears SD, Fox R, Brookmeyer R, Leavitt R, Polk BF. Delayed hyper-sensitivity skin testing and anergy in a population of gay men. Clin Immunol Immunopathol 1987;45:177-83.
17. Centers for Disease Control and Prevention. Prevention and control of tuberculosis in correctional facilities: Recommendations of the Advisory Council for the Elimination of Tuberculosis. MMWR 1996; 45:1-26.
18. Hutton MD, Cauthen GM, Bloch AB. Results of a 29-state survey of tuberculosis in nursing homes and correctional facilities. Public Health Rep 1993;108:305-13.
19. Nardell EA. Tuberculosis in homeless, residential care facilities, prisons, nursing homes, and other close communities. Semin Respir Infect 1989;4:206-15.
20. Valway SE, Richards SB, Kovacovich J, Greifinger RB, Crawford JT, Dooley SW. Outbreak of a multi-drug-resistant tuberculosis in a New York State prison. Am J Epidemiol 1994;140:113-22.
21. Robles RR, Marrero CA, Reyes JC et al. Risk behaviors, HIV sero-positivity, and tuberculosis infection in injecting drug users who operate shooting galleries in Puerto Rico. J AIDS 1998;17:477-83.
22. Fisher D, Needle R, Weatherby N, Brown B, Booth R, Williams M. Reliability of drug user self-report. IX International Conference on AIDS 1993;2:776. (Abstract)